Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Novel Therapeutic Technologies

Request full access

Novel Therapeutic Technology develops practical drug delivery systems

Wilmington, United StatesFounded 2003Biotech & Life Sciences

About Novel Therapeutic Technologies

Novel Therapeutic Technologies (NTT), Inc. was a biopharmaceutical firm established in 2003 with its headquarters in Wilmington, Delaware, and an operational presence in Israel. The company was steered by CEO Yitzhak Turkeltaub. NTT operated within the drug delivery sector, focusing on enhancing the application and efficacy of topical medications for pharmaceutical partners.

The core of the company's intellectual property was its Ethosome technology, a non-invasive transdermal delivery system. This platform utilized soft, malleable vesicles composed of phospholipids and a high concentration of ethanol to carry active pharmaceutical ingredients through the skin's outer layer. The primary benefit of this approach was to significantly increase the penetration of drugs into the skin, thereby boosting therapeutic effectiveness while potentially lowering required dosages and reducing side effects. The technology was versatile, capable of encapsulating both lipophilic and hydrophilic molecules for a wide range of potential applications, including antibiotics and anti-inflammatory drugs.

NTT's business model involved collaborating with pharmaceutical companies to reformulate their existing drugs using the Ethosome system, aiming to create enhanced, patentable products. In addition to these partnerships, the company also developed its own private label offerings, including an anti-cellulite product that leveraged the Ethosome platform. The company secured a substantial Series D funding round of $75 million in late 2011, a significant capital injection intended to advance its development programs. Despite this funding, corporate activity appears to have ceased in the following years, and the company is now reported as being out of business.

Source: Dealroom company data

At a glance

Status
Closed
Employees
1
Open positions
None listed
Industry
Health, Transportation
Sub-industry
BioTechnology, Logistics & Delivery
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Dec 2011 $75M $525M Undisclosed —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Novel Therapeutic Technologies website traffic

Latest recorded traffic for Novel Therapeutic Technologies is 0 monthly website visits. Novel Therapeutic Technologies's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Novel Therapeutic Technologies in the Wilmington ecosystem

Live from Dealroom

The Novel Therapeutic Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Wilmington HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Novel Therapeutic Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novel Therapeutic Technologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.